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ABSTRACT
Ocular morphogenesis requires several signalling pathways
controlling the expression of transcription factors and cell-cycle
regulators. However, despite a well-known mechanism, the dialogue
between those signals and factors remains to be unveiled. Here, we
identify a requirement for MarvelD3, a tight junction transmembrane
protein, in eye morphogenesis in Xenopus. MarvelD3 depletion led to
an abnormally pigmented eye or even an eye-less phenotype, which
was rescued by ectopic MarvelD3 expression. Altering MarvelD3
expression led to deregulated expression of cell-cycle regulators and
transcription factors required for eye development. The eye
phenotype was rescued by increased c-Jun terminal Kinase
activation. Thus, MarvelD3 links tight junctions and modulation of
the JNK pathway to eye morphogenesis.
KEY WORDS: MarvelD3, Xenopus eye, Tight junction, C-Jun
N-terminal Kinase
INTRODUCTION
Eye morphogenesis is an evolutionarily conserved feature of most
organisms to ensure an efficient communication with the
environment (Gilbert, 2000). Eye development is a complex
multi-step process, which involves cell proliferation, migration,
cell-fate determination, survival and differentiation (Fuhrmann,
2008; Gilbert, 2000; Harada et al., 2007). After the neural antero-
posterior patterning of the embryo, several signals, such as
bone morphogenetic protein (BMP), fibroblast growth factor
(FGF) and non-canonical Wnt, promote the expression of eye-
field transcription factors (EFTFs). EFTFs specify a single eye-field
in the most anterior region of the neural plate. In this region,
inhibition of cell-cycle activators occurs to favour EFTF expression,
while duration of the expression of the transcription factors is
established by cell-cycle-independent factors (Bilitou and Ohnuma,
2010; Cavodeassi et al., 2005; Gilbert, 2000; Harada et al., 2007;
Zuber, 2010). The single eye-field is then divided into two eye
primordia under the influence of Sonic hedgehog signalling
(Chiang et al., 1996; Gilbert, 2000; Roessler et al., 1996;
Takabatake et al., 2002). These eye primordia are characterized by
a highly mitotic activity due to an enhanced expression of cell-cycle
activators. This proliferative step, driven by cyclins and cyclin-
dependent kinases, allows the appropriate number of retinal
precursors to be reached (Bilitou and Ohnuma, 2010; Harada
et al., 2007). During this process, the optic vesicle invaginates and
reaches the surface ectoderm. The dialogue between the optic
vesicle and the ectoderm then specifies the lens placode, which is
internalized and induces the development of the cornea from the
surface ectoderm (Bilitou and Ohnuma, 2010; Gilbert, 2000;
Harada et al., 2007; Zuber, 2010). In the optic vesicle, the fate of the
retinal precursors is determined during the last-division step before
their final differentiation (Bilitou and Ohnuma, 2010; Zuber, 2010).
A non-canonical Wnt signal is then subsequently required for the
final differentiation of the retinal progenitors into the cell types that
make up the inner and outer retinal cell layers: glia, ganglion cells,
interneurons, photoreceptors and the retinal pigment epithelium
(RPE) (Gilbert, 2000; Harada et al., 2007; Maurus et al., 2005).
Most of the main eye components are derived from epithelia.
Epithelial integrity is preserved by tight junctions (TJ), adherens
junctions (AJ) and desmosomes (Balda and Matter, 2008; Eckert
and Fleming, 2008; Fleming et al., 2000a,b; Ripley et al., 2004; Wei
and Huang, 2013). MarvelD3 (MD3), a TJ transmembrane protein,
belongs to the tight junction-associated MARVEL domain protein
family, which also includes occludin and tricellulin (Cording et al.,
2013; Raleigh et al., 2010; Shen et al., 2011; Steed et al., 2009).
In the eye, occludin and tricellulin are thought to contribute to
the compartmentalisation of the ocular micro-environments by
controlling the flux through the retinal-blood barrier (Erickson et al.,
2007; Huet et al., 2011; Iwamoto et al., 2014; Muthusamy et al.,
2014; Tserentsoodol et al., 1998). Our previous work showed MD3
expression in corneal and RPE-derived cell lines (Steed et al.,
2009). Additionally, MD3-mediated c-Jun N-terminal kinase (JNK)
inhibition modulates cell proliferation, migration and survival
in vitro (Steed et al., 2009). However, the function of MD3 in eye
development has not been explored. Given the role of MD3 in the
regulation of the JNK pathway, analysing its function in eye
morphogenesis may lead to new insights into eye morphogenesis
and the role of TJ-associated signalling mechanisms. We speculated
that MD3 plays a role in the establishment of the complex regulatory
systems that mediate eye morphogenesis and in the spatio-temporal
regulation of the interplay between expression of EFTFs and cell-
cycle regulators (Bilitou and Ohnuma, 2010; Zuber, 2010).
Here, we asked whether MD3 is involved in eye morphogenesis
in Xenopus. We show that MD3 is expressed in the eye region
similarly to JNK and that MD3 depletion disrupted the normal
expression pattern of EFTFs, the balance between cell proliferation
and survival, and led to the development of smaller eyes or to anReceived 7 April 2016; Accepted 20 September 2016
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eye-less phenotype. Similarly, MD3 overexpression affects the
expression patterns of EFTFs, cell proliferation and survival but,
contrary to MD3 depletion, overexpression led to no visible eye
phenotype except a more compact lamination of the retina. These
findings support a new role for MD3 as a regulator of ocular
morphogenesis. Unexpectedly, the eye phenotype was not caused
by increased JNK signalling but could be rescued by stimulating the
JNK pathway in MD3-depleted embryos. Our data suggest that
MD3 acts as a linker between the signals inducing eye
morphogenesis, specification of the eye field by EFTFs, and
survival and differentiation of multiple ocular cell types.
RESULTS
Structure and expression of MarvelD3 in the eye field
XenopusMD3 (GenBank accession number, BC 068841) encodes a
420 amino acid (AA) protein with an amino-terminal intracellular
domain followed by four transmembrane domains, two extracellular
loops and an 18 AA cytoplasmic carboxy-terminal domain
(Fig. 1A). Xenopus MD3 closely resembles isoform 2 of human
MD3 (Steed et al., 2009). We first analysed the spatial distribution
of MD3 expression by whole-mount in situ hybridization (WISH)
and found that theMD3 transcript is broadly expressed in the animal
pole before gastrulation (Fig. S1A,B). At the neurula stage, MD3 is
enriched in the anterior region of the embryo, similarly to Rx1
(Retina homeobox 1), an eye marker (stage 15; Fig. 1B,C).
Consistently, at tail-bud stages, MD3 is expressed in the head region
(stage 25; Fig. S1C and Fig. 1D,D′), partially overlapping with Rx1
expression (Fig. 1E). To further substantiate our data on MD3
expression in the eye, we performed a RT-PCR analysis of the
transcript using RNA purified from isolated optic vesicles (stage 25)
and eyes (stage 42). Consistently with the results from the spatial
analysis of MD3 expression, the transcript was detected in RNA
derived from the eye field at both stages (Fig. 1F).
We previously showed that MD3 acts as an inhibitor of the JNK
pathway (Steed et al., 2014), and MD3 distribution in Xenopus
embryos is reminiscent of that of JNK and JNK activators
(Fuhrmann, 2008; Hirai et al., 2005; Kibardin et al., 2006; Kim
et al., 2005; Yamanaka et al., 2002). To determine in which region
of the eye MD3 is expressed, we sectioned labelled embryos and
detected MD3 expression in the lens, and in the inner and outer
plexiform layers (Fisher, 1976) (Fig. 1G). MD3 is thus expressed in
the head and, particularly, in specific tissues and cell layers of the
developing eye.
MD3 is required for the eye morphogenesis
To determine the functional importance of MarvelD3 for eye
development, we designed two morpholino (MO) antisense
oligonucleotides that block MD3 translation, one targeting the
5′-UTR (untranslated region; MD3A MO) and the other at the start
of the ORF (open reading frame; MD3BMO) of MD3. Inhibition of
MD3 expression by MD3 MO was confirmed by immunoblotting
(Fig. S2A).
First, we asked whether MD3MOs cause morphological changes
during embryogenesis by injecting the dorsal animal region of a
blastomere at the 2-cell stage. During gastrulation and neurula stages,
no apparent morphological defects were observed (Fig. S2B-C).
In contrast, at tailbud stage, injection of MO either individually or
together (MD3A MO, 85.4±2.66%; MD3B MO, 93.9±1.04%;
MD3AB MO, 88.7±2.96%) showed a patchy or absent retinal
pigmentation, while control (CT) MO-injected embryos (91.5±
1.26%) presented an intact ocular pigmentation (Fig. 2A-C and F),
supporting the specificity of the MO-induced eye phenotype. To
Fig. 1. MD3 structure and expression in Xenopus embryo. (A) Xenopus laevisMD3 (MD3; Genbank: BC 068841) protein includes three intracellular (IC, red),
four transmembrane (TM, green) and two extracellular (EC, blue) domains. Numbers correspond to the amino acids. Spatial analysis of expression of MD3
transcript (B,D,D′) and an eye marker Rx1 (C,E) was performed by whole-mount in situ hybridization (WISH) in neurulas (stage 15, B) and tadpoles (stage 38,
D,D′). Scale bar: 500 μm; black arrowhead, eye; white arrowhead, lens. (F) MD3 expression analysis by semi-quantitative RT-PCR using RNA isolated from
dissected optic vesicles (stage 25) and eyes (stage 42). GAPDHwas amplified as a control. bp, base pairs. (G) MD3 signal was detected byWISH in the inner and
outer plexiform layers (red arrowheads) and in the lens (white arrowhead) on eye sections (stage 42).
1632
RESEARCH ARTICLE Biology Open (2016) 5, 1631-1641 doi:10.1242/bio.018945
B
io
lo
g
y
O
p
en
further substantiate the specificity of the observed phenotype, we
performed rescue experiments by co-injecting MO with
corresponding non-targeted mRNA. For MD3A MO, which
targets a sequence in the 5′-UTR, we co-injected mRNA
representing the coding region of MD3 (MD3 FL); and with
MD3B MO, which binds at the start of the coding sequence, the
mRNA encoded a mutated form carrying silent mutations in the
MD3B MO targeting sequence (7mut-MD3). Both rescue
approaches resulted in recovery of normal retinal pigmentation
(97.4%±0.43 and 78.1%±1.63, respectively), suggesting the
restoration of apparently normal eye development (Fig. 2D-E′ and
F). Thus, the phenotype induced by MD3 MOs is specific and
indicates that MD3 is required for eye development.
We then performed a more detailed investigation of the ocular
structure to identify cell types affected in MD3 morphants.
Histological analysis revealed a strong disorganisation of the
overall eye structure, loss of retinal lamination, and absence of RPE
(black pigmented ring) in MD3 MO injected embryos (Fig. 2G-H).
Fig. 2. MD3 KD disrupts eye morphogenesis. Alteration of eye morphology was analysed (A-E′) and quantified (F) in non-injected (NI), CT, MD3A, MD3B,
MD3AB MO-injected embryos and embryos co-injected with MD3A MO and FL MD3 mRNA or MD3B MO and 7-mut MD3 mRNA. Lateral (A-E) and dorsal view
(A′-E′) of the embryo; white arrow, level for dorsal view; black rectangle, eye; red asterisk, injected side of the embryo in all figures. Numbers indicate the embryos
analysed. Crop of the eye (G-H) and head transversal section without (G′-H″) or with a hematoxylin & eosin (H&E) staining (G′″-H′″) were analysed in wild-type
(wt) and MD3B MO embryos. Red arrow, retinal pigment epithelium (RPE); white arrowhead, eye region; dotted red line, remaining eye tissue. Analysis by
immunohistochemistry on eye sections from wt and MD3B MO-injected embryos was performed for lens cells (β-crystallin, I-I′), rod photoreceptors (Rhodopsin;
J,J′) and ganglion cells (Hu-C/Hu-D, K-K′), and the number of positive cells for each eye marker was quantified as described in the Materials and methods (L);
numbers indicate the eye sections quantified. Statistical significancewas assessed by Student’s t-test in F (P values, CTMO=0.14; MD3AMO=8.99*10−5; MD3B
MO=2.21*10−5; MD3AB MO=2.74*10−6; MD3A MO+MD3 FL RNA=0.18; MD3B MO+7mut-MD3 RNA=6*10−2, NS: non significant; ***P<0.001), and
Mann–Whitney test in L (P values, β-crystallin=1.59*10−2; Rhodopsin=1*10−4; Hu-C/Hu-D=1.92*10−2, *P<0.05 and **P<0.01). Scale bars: 500 µm (A-E,G,H)
and 100 μm (I-K). Embryos were analysed at stage 42.
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Staining of sections for markers of specific ocular cell types further
corroborated a retinal defect (Fig. 2I-K). Quantification of such
images revealed reduced numbers of lens epithelial cells positive for
β-crystallin (15.99%±6.7), ganglion cells positive for Hu-C/Hu-D
(60.9%±15.38), and rod photoreceptors positive for rhodopsin
(8.75%±4.6). Moreover, the remaining rod photoreceptors formed
mislocalized clusters (Fig. 2I-L). MD3 is thus required for eye
development and, in particular, for the formation of a laminated
retina and differentiated lens.
As a complementary approach, we injected FL MD3 mRNA to
overexpress MD3. MD3 overexpression did not have any evident
morphological effects on gastrula, neurula and early tailbud
development (Fig. S3). Additionally, MD3 overexpressing
tadpoles did not present any visible eye phenotype (Fig. 3A-C),
Fig. 3. MD3 overexpression changes eye lamination. Eye morphology was analysed (A-B′) and quantified (C) in non-injected (NI), GFP or FL MD3
mRNA-injected embryos (P values in C, GFP RNA=0.89; FL MD3 RNA=0.26; NS: non significant). Lateral (A,B) and dorsal view (A′,B′) of the embryo; GFP
mRNA was used as a control. Red asterisk, injected side of the embryo. (D,E), The eye size was quantified for GFP or FL MD3 mRNA-injected embryos, as
described in the schemes and in theMaterials andmethods. Numbers indicate the embryos analysed; NS, non significant.P values in D, GFPRNA=0.66; FLMD3
RNA=0.91; P values in E, GFP RNA=0.46; FL MD3 RNA=0.52; NS, non significant. (F,G) Histological analysis by H&E staining was performed on eye sections
from GFP and FL MD3 mRNA-injected embryos and the number of cells was quantified as described in the Materials and methods. (H) Number of cell were
quantified per eye section stained byH&E derived fromGFPor FLMD3RNA-injected embryos. Numbers indicate the eye sections quantified;P value=1.26*10−6,
***P<0.001. Immunohistochemistry on eye sections from GFP and FL MD3 mRNA-injected embryos was perfomed for β-crystallin (I-I′), rhodopsin (J,J′),
Hu-C/Hu-D (K-K′). (L) Number of positive cells for each eye marker was quantified as described in the Materials and methods. Numbers indicate the eye sections
quantified; P values, β-crystallin=0.19; Rhodopsin=0.87; Hu-C/Hu-D=0.74; NS, non significant. Statistical significance was assessed by Mann–Whitney (C,L)
and Student’s t-test (D,E,H). Scale bars: 500 µm (A,B) and 100 μm (I-K). Embryos were analysed at stage 42.
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such as altered retinal pigmentation, lens:retina ratio or eye size
(Fig. 3D,E). In sections, however, the retina appeared more compact
because of an increased number of cells in theMD3 overexpressing-
embryos (Fig. 3F-H). However, this change in cell numbers did not
affect lens epithelial cells, ganglion cells and rod photoreceptors
(Fig. 3I-L). Altogether, these results suggest that MD3 plays a
functionally important role in Xenopus eye development and
morphogenesis.
MD3 regulates the optic fate of cells-derived from
blastomeres A1 and A3
The active Spemann organizer favours normal eye morphogenesis
(Bailey et al., 2004; Kim et al., 2005) and convergent extension
(Itoh and Sokol, 1999); consequently, the MD3 MO-induced eye
phenotype might be due to a dysfunctional mesodermal signal. A
mesoderm contribution is unlikely, however, as no shortening of the
antero-posterior axis was evident in MD3 morphants (Fig. 2). To
rule out the mesoderm involvement, MD3 MOs were injected in a
dorsal animal blastomere at the 8-cell stage. This injection also led
to the reduced eye phenotype (93%±0.62; Fig. 4A). Hence, the eye
phenotype of MD3 depleted embryos is mesoderm-independent.
At 32-cell stage, the eye only derives from nine blastomeres in
Xenopus, among which the main contributors in the animal pole are
(from dorsal to ventral): A1 and A3 for retinal cells, and A1, A3 and
A4 for lens cells (Moody, 1987). In addition to their ocular
contribution, A1, A3 and A4 blastomeres give rise mainly to the
neural ectoderm, neural crest and epidermis, respectively (Fig. 4B).
Thus, we asked which of these blastomeres participates in the MD3
MO-eye phenotype by injecting them with MD3 MOs. Fig. 4C-E
shows that A1- and A3-injected embryos presented defective eye
morphogenesis, but not A4-injected embryos. This suggests that A1
and A3 blastomeres, which mainly develop into neural and neural
crest-derived cell types, are responsible for the observed eye
phenotype. Hence, MD3 plays an important role during the
development of the neural linage that is essential for eye
development.
MD3 controls cell proliferation and survival in the eye field
Given the contribution of the anterior neural plate region in the eye
phenotype, we asked whether MD3 might be necessary for early
eye-field formation as a step towards identifying its temporal
involvement in eye development. We first analysed by WISH the
expression patterns of the EFTFs: retinal homeobox 1 (Rx1), Paired
box 6 (Pax6), and Orthodenticle homeobox 2 (Otx2) in neurulas
(stage 17) and tadpoles (stage 30) depleted for MD3. Rx1 is a
specific eye-field marker, whereas Pax6 is also expressed in
the spinal cord and Otx2 at the forebrain/midbrain boundary
(Maurus et al., 2005). Rx1 (Fig. 5A-B), Pax6 (Fig. 5C-D) and Otx2
(Fig. 5E-F) expression domains were initially enlarged in the eye-
field region of neurulas and then subsequently reduced in tadpoles.
These data suggest that MD3 depletion might deregulate the balance
between proliferation and survival during early eye-field
morphogenesis. To validate this hypothesis, we first established
the expression pattern of the cell-cycle marker cyclin D1 and then
measured cell proliferation and apoptosis. The cyclin D1 expression
domain was enlarged in 91% of embryos at stage 17 and reduced
in the eye field of 89.5% of embryos at stage 30 (Fig. 6A-B),
indicating that down-regulation of MD3 affected proliferation.
Consistently in MD3 morphants, an increase in the number of
dividing cells was observed in neurulas (612%±88.52 BrdU-
positive cells; Fig. 6C), followed by a massive apoptotic wave in
tadpoles (1216.7%±142,6 TUNEL-positive cells; Fig. 6D).
To reinforce the role of MD3 during early eye morphogenesis,
we analysed the impact of MD3 gain-of-function on the expression
domains of the EFTFs in neurulas (stage 17), tailbuds (stage 25)
and tadpoles (stage 30). Rx1, Pax6 and Otx2 expression domains
were mildly enlarged at neurula stage (Fig. 7A,C and E). In
tailbuds and tadpoles, we observed a moderate expansion of the eye
field (Fig.7B,D,F and Fig. S4). Similarly to our observations in
MD3 depleted embryos, these data suggest a potential deregulation
of cell proliferation and death. Indeed, the number of proliferating
cells was increased in MD3-overexpressing embryos although
more modestly than in the MD3 morphants (244% ±19.07 BrdU-
positive cells; Fig. 7G). In contrast, apoptosis in tadpoles was
reduced (59.3%± 10TUNEL-positive cells; Fig. 7H), which is in
agreement with the increased cell numbers observed in eye
sections. Altogether these data demonstrate that MD3 modulates
cell proliferation in the early eye field and regulates cell survival
during eye morphogenesis.
MD3 activates the JNK pathway for eye morphogenesis
Building an eye requires complex regulation of multiple signalling
pathways (Zuber, 2010).
Fig. 4. The MD3 MO-induced eye phenotype originates from neural plate
and crest but not mesoderm. (A) Alteration of eye morphology was
quantified in embryos injected with MD3 MOs in one dorsal blastomere at
8-cell stage. NS, non significant; **P<0.01. Student’s t-test (P values, CT
MO=0.34; MD3AB MO=1*10−2). (B) Scheme representing the dorsal
blastomeres A1, A3 and A4 of an embryo at 32-cell stage. A, animal pole;
V, vegetal pole; V, ventral; D, dorsal (scheme adapted from Xenbase).
Alteration of eye morphology was analysed and quantified in embryos
injected with MD3 MOs in one dorsal blastomere A1, A2 or A4 at 32-cell
stage (C-E′). Note the disrupted eye morphology in A1- and A3-injected
embryos. Scale bar: 500 µm; numbers indicate the embryos analysed at
stage 42; red asterisk, injected side of the embryo.
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Our previous in vitro study demonstrated that MD3 acts as a
modulator of the JNK pathway and controls gene expression, cell
proliferation and survival (Steed et al., 2014). The expression
pattern of MD3 in vivo is similar to that of JNK and thus raises the
question whether MD3 and JNK act together to regulate eye
morphogenesis (Garriock et al., 2005). Increased JNK/AP1 activity
in MD3 morphants is compatible with the enhanced proliferation
observed in the early eye field, however, normal eye morphogenesis
is thought to require JNK signalling in Xenopus due to activation of
a non-canonical Wnt pathway (Lee et al., 2006; Maurus et al., 2005;
Valesio et al., 2013). Hence, it could be that MD3 plays a more
complex role in JNK pathway regulation than that of a simple
repressor.
To determine the role of JNK downstream of MD3 in eye
morphogenesis, we first tested whether inhibition of JNK affects
ocular development. We added increasing concentrations of the
JNK inhibitor SP600125 before eye field specification at stage
11 and then removed it at stage 22, when the eye field is defined.
Modulation of JNK signalling with low concentrations of
SP600125 indeed affected eye morphogenesis: the lens:retina
ratio increased in a dose-dependent manner (0.25 to 1 μg ml−1;
Fig. 8). Higher concentrations of the inhibitor disrupted
convergent extension, a process in which JNK plays a key
role. However, ocular development seems exquisitely sensitive
to JNK inhibition as it was already affected at low
concentrations of SP600125 that did not seem to affect
convergent extension.
Our previous studies indicate that MD3 attenuates the JNK
pathway in vitro (Steed et al., 2014). Thus, we first treated MD3
MO-injected embryos at concentrations of SP600125 that did not
Fig. 5. MD3 KD affects early eye-field formation. Eye-field
specification was analysed by WISH against the eye markers
Rx1, Pax6, Otx2 in neurulas (stage 17; anterior view; A,A′,C,C′,
E,E′) and tailbuds (stage 30; B,B′,D,D′,F,F′) injected with CT or
MD3 MOs. Black dotted line, midline of embryo; arrowhead,
enlarged (A′,C′,E′) and reduced (B′,D′,F′) expression domain
of the eye markers; red asterisks, injected side of the embryo;
numbers indicate the embryos analysed. Scale bar: 500 µm.
Fig. 6. MD3 KD stimulates cell proliferation
and apoptosis in the eye field. Eye-field
proliferation was analysed by WISH against
cyclinD1 in neurula (stage 17; anterior view; A-A′)
and tailbud (stage 30; B-B′) injected with CT or
MD3 MOs. Black dotted line, midline of embryo;
arrowhead, enlarged (A′) and reduced (B,B′)
expression domain of cyclinD1; red asterisks,
injected side of the embryo; numbers indicate the
embryos analysed. Scale bar: 500 µm. Cell
proliferation in the anterior region of the neurula
was quantified with a BrdU staining (C) and cell
death with a TUNEL assay in tailbud (D) as
described in the Materials and methods;
Student’s t-test (P values, BrdU in C, CT
MO=0.16, MD3AB MO=9.4*10−6; TUNEL in D,
CT MO=7*10−2, MD3AB MO=5.66*10−9). The
numbers indicate the embryos analysed (A-B′,D)
or the sections counted (C). NS, non significant;
***P<0.001.
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affect convergent extension from stage 11 to 22. JNK inhibition did
not rescue the eye phenotype in MD3 morphants, in contrast, the
phenotype deteriorated even further (Fig. S5). Hence, a simple
model in which MD3 attenuates the JNK pathway during eye
development does not appear to be correct.
We next hypothesised that MD3 morphants might have a reduced
activity of the JNK pathway perhaps due to JNK deregulation during
earlier steps of development. We first asked whether overexpression
ofMD3 can enhance activity of AP1, a transcription factor stimulated
by JNK, in a reporter gene assay in Xenopus embryos at stage 12.
Fig. 9A shows that overexpression of both c-Jun, used as a positive
control, and MD3 increased AP1 activity. Hence, increased MD3
expression can stimulate AP1 activity in some cellular contexts.
If the eye phenotype is caused by reduced activity of the JNK
pathway, it should be possible to rescue normal eye development by
stimulating JNK signalling. Therefore, we next asked whether
co-injecting wild-type JNK (wt JNK) or constitutively active JNK
(CA-JNK) could rescue the eye phenotype in MD3 morphants.
Indeed, wt JNK and CA-JNKmRNAs rescued the eye phenotype in
MD3 morphant embryos (Fig. 9B-E). These data thus suggest that
reduced JNK activity in MD3 morphants underlies the eye
morphogenesis phenotype.
DISCUSSION
During Xenopus embryogenesis, MD3 is enriched in the lens and
plexiform layers, key components for eye morphogenesis. MD3
depletion affected the formation of both the lens and the retina by
reducing the number of lens epithelial cells, ganglion cells and
photoreceptors, respectively. In the early eye-field, MD3 modulates
the balance between cell proliferation and survival, and eye
morphogenesis requires activation of the JNK pathway
downstream of MD3.
Fig. 7. MD3 overexpression affects the balance between cell proliferation and apoptosis in the eye field. Eye-field specification was analysed by WISH
against the eye markers Rx1, Pax6, Otx2 in neurulas (stage 17; anterior view; A,A′,C,C′,E,E′) and tailbuds (stage 30; B,B′,D,D′,F,F′) injected with GFP or
MD3 RNAs. Black dotted line, midline of embryo; green and red lines, enlarged expression domain of the eye markers; red asterisks, injected side of the embryo;
numbers indicate the embryos analysed. Scale bar: 500 µm. Cell proliferation in the anterior region of the neurula was quantified with a BrdU staining (G) and
cell death with a TUNEL assay in tailbud (H) as described in the Materials and methods; Student’s t-test (P values, BrdU in G, GFP RNA=0.94, FL MD3
RNA=2.1*10−5; TUNEL in H, GFP RNA=0.8, FL MD3 RNA=2*10−3). The numbers indicate the embryos analysed (H) or the sections counted (G). NS, non
significant; **P<0.01 and ***P<0.001.
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MD3 is required foreyemorphogenesis through JNKpathway
activation
MD3 expression strongly recalls the spatial distribution of JNK in
Xenopus (Yamanaka et al., 2002). The activators of JNK, mitogen-
activated protein kinase kinase 7, Plenty of SH3s (POSH), MAP
kinase upstream kinase and metastasis-associated kinase (MAK)
also present a similar expression pattern (Fuhrmann, 2008; Hirai
et al., 2005; Kibardin et al., 2006; Kim et al., 2005; Yamanaka et al.,
2002). This similar spatial distribution and the in vitro function of
MD3 as a JNK regulator support the idea that MD3 also regulates
the JNK pathway in vivo during the eye morphogenesis.
JNK signalling is activated during embryonic development
following exposure to growth or differentiation factors (Valesio
et al., 2013). Consequently, several studies linked JNK to eye cell
differentiation and eye morphogenesis induced by such factors.
Wnt4 depleted embryos lose the expression of EFTFs and develop
smaller eyes through the inactivation of the non-canonical Wnt/
JNK pathway (Maurus et al., 2005). Interestingly, Kibardin et al.
Fig. 8. JNK inhibition disrupts eye
morphogenesis. (A-E) The morphology of the
eye was analysed in wild-type embryos treated
from stage 11 to 22 with DMSO or increasing
concentrations of SP600125, a JNK inhibitor.
Scale bar: 500 µm. (F) The eye size was
quantified from the embryos (A-E) as described in
theMaterials andmethods; Mann–Whitney test (P
values, 0.25 μg ml-1=0.93; 0.5 μg ml-1=7.8*10−5;
1 μg ml-1=1.02*10−8; 2.5 μg ml-1=1.07*10−5).
The numbers indicate the embryos analysed.
Note, the embryos show reduced eye formation in
a dose-dependent manner. NS, non significant;
***P<0.001.
Fig. 9. MD3-induced JNK activation is required for eye morphogenesis. (A) Activity of the reporter plasmid AP1-Luc (JNK pathway) was determined by
Luciferase assay from whole-embryos (stage 12) co-injected with Renilla (as a control), c-Jun (as positive control) or FL MD3 mRNA. The morphology of the eye
was analysed at stage 42 (B-C′), quantified (D) and the eye size determined (E) in embryos injected with MD3 MOs, co-injected with wt JNK or CA-JNK mRNA.
Scale bars: 500 µm. The numbers indicate the embryos analysed. Statistical significance was assessed by Student’s t-test (P values in A, positive CT=2.6*10−3;
MD3 RNA=3.5*10−3) and Mann–Whitney test (P values in D, MD3AB MO=0.02; MD3AB MO+wt JNK RNA=0.06; MD3AB MO+CA-JNK RNA=0.19; P values in
E, MD3AB MO=1.65*10−9; MD3AB MO+wt JNK=1.4*10−3; MD3AB MO+CA-JNK=4.37*10−6). *P<0.05; **P<0.01; ***P<0.001; NS, non significant.
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(2006), proved that MAK stimulates the non-canonical Wnt
pathway to promote eye morphogenesis in Xenopus (Kibardin
et al., 2006). Kim et al., (2005) also demonstrated that POSH-
induced JNK activation regulates the anterior neural development
including eye formation through the control of cell survival
(Kim et al., 2005). Our data indicate that MD3 activation of the
JNK pathway is required for normal eye development, consistent
with these previous studies (Fig. 9). Thus, future detailed analysis
of head structure and brain patterning will enable generalizing
the mechanism driving eye formation and anterior neural
development.
Several studies used the chemical SP600125 to inhibit JNK
signalling by preventing c-Jun phosphorylation (Maurus et al.,
2005; Valesio et al., 2013; Yamanaka et al., 2002). Zebrafish and
Xenopus embryos treated with SP600125 (Figs 8 and 9 and Fig. S5)
present an underdeveloped retina and lens, strengthening the
requirement for JNK during eye morphogenesis. The use of
this drug in zebrafish can lead to side effects unrelated to JNK
inhibition due to its function as a partial agonist of 2, 3, 7, 8-
TetraChloroDibenzo-p-Dioxin (Valesio et al., 2013). However,
analysis performed in amphibians showed insignificant side effects
(Collier et al., 2008), making it a reliable approach to study the role
of JNK.
In addition to the eye phenotype, JNK-inactivated zebrafish
embryos also present a reduced anterior-posterior axis
corresponding to defective convergent extension movement
(Valesio et al., 2013). In Xenopus, convergent extension
movements and eye development occur via the activation of the
non-canonical Wnt pathway and, more precisely, Wnt5 is
responsible for JNK activation during convergent extension
(Yamanaka et al., 2002). During eye development, the activation
of the non-canonical Wnt pathway down-regulates the canonical
Wnt signal (Kibardin et al., 2006); this switch is also responsible for
eye morphogenesis in zebrafish (Cavodeassi et al., 2005).
Altogether these studies corroborate a common origin for eye
morphogenesis and convergent extension that might be regulated by
the signals from the Spemann organizer. However, the MD3 MO-
induced eye phenotype was not due to an effect on the mesoderm
(Fig. 4A). Moreover, the length of the embryo was not affected and
no dorsal flexure was visible following MD3 depletion (Fig. 2A-C).
However, our findings do not exclude an involvement of non-
canonical Wnt signalling, and it will be interesting to explore
whether MD3 affects the role of JNK in the non-canonical Wnt
pathway.
MD3, a modulator of cell proliferation and survival
JNK regulates cell survival in vitro and in vivo as a consequence of
its increased or decreased activity (Hao et al., 2015; Pushpavalli
et al., 2015; Steed et al., 2014; Valesio et al., 2013; Weston and
Davis, 2002). This dual-action of JNK suggests a high degree of
complexity in the regulation of cell survival depending on the
conditions and model analysed. Hence, it is essential to ensure
proper temporal control of JNK activity.
At stage 17, increased expression of EFTFs (Rx1 Pax6, Otx2;
Fig. 5A-E) and hyper-proliferation characterized MD3 morphants
(Fig. 6A,C); followed by increased apoptotic activity (Fig. 6B,D)
and a reduced eye field (Fig. 5B-F) at stage 30. Interestingly,
overexpression ofMD3 in neurula, tailbud and tadpole also led to a
mild enlargement of the expression domains of EFTFs (Fig. 7A-F
and Fig. S4), correlating with a small increase in proliferating cells
(Fig. 7G) and reduced apoptosis (Fig. 7H). Modulation of the eye-
field size by manipulation of MD3 expression is thus mirroring a
defective balance between proliferation and survival. Disruption of
this balance might originate fromMD3 control of cell proliferation
and survival through JNK activity (Steed et al., 2014) or
deregulated expression of cell-cycle activators due to altered
levels of EFTFs (Bilitou and Ohnuma, 2010; Zuber, 2010). Cell
cycle regulators like cyclin D1 are JNK/AP-1 target genes; hence
MD3 may regulate expression of at least some cell cycle regulators
via the JNK pathway also in Xenopus. In vitro, MD3 depletion
induces JNK activity, leading to increased proliferation as
highlighted by enhanced cyclin D1 expression and AP1 activity
(Steed et al., 2014). In this study, we demonstrate that MD3
depletion in vivo reduces JNK signalling leading to abnormal eye
morphogenesis, and that this phenotype can be rescued by JNK
overexpression. However, it is possible that the JNK rescue only
affects steps of eye morphogenesis following eye-field
specification, as an enlarged eye field, such as the one observed
at stage 17, does generally not lead to an eyeless phenotype but
rather to giant eyes. The effect of MD3 on the JNK pathway seems
to be stimulus and cell-type dependent, and its depletion can thus
affect activity of the JNK pathway either negatively or positively.
This is supported by the observation that increased MD3
expression in stage 12 embryos resulted in increased in AP-1
activity (Fig. 8A), whereas MD3 expression in cultured cells
inhibits AP-1 (Steed et al., 2014).
Another possibility is that MD3 depletion-induced hyper-
proliferation is a JNK-independent mechanism and that MD3
depletion disrupts expression of EFTFs, which, in turn, control
expression of cell-cycle regulators. Overexpression of EFTFs such as
Rx does not only stimulate eye field proliferation but also leads to a
giant eye phenotype (Zuber, 2010; Zuber et al., 1999), this suggests
that an additional effect induced byMD3 depletion must take place as
we obtained smaller eyes or even an eyeless phenotype in MD3
morphants. This additional effect is likely to lead to reduced JNK
pathway activity and to take place after the initial induction of the eye
field as the smaller eye phenotypewas rescued by JNKoverexpression.
To conclude, we demonstrate that MD3-induced JNK pathway
activation is required for proper eye morphogenesis in Xenopus.
This study identifies MD3 as an inhibitor of the expression of
EFTFs, acting downstream of the inducing signalling molecules;
hence, MD3 is a regulatory cornerstone of eye morphogenesis.
Further insight into the role of the MD3/JNK pathway during eye
development will be required to determine the up- and down-stream
signalling mechanisms governingMD3 expression and to unveil the
spatio-temporal distribution of active JNK in the eye field.
MATERIAL AND METHODS
Xenopus laevis and drugs
Animals were purchased from Nasco (Salida, California), used under Act
1986 (UK Home Office) according to the UK Home Office ethical approval
and guidance and University Animal Welfare Committee. The embryos
were staged using Nieuwkoop tables (Nieuwkoop and Faber, 1994). DMSO
(dimethyl sulfoxide; Sigma) or SP600125 (Tocris) was added at the
indicated concentrations during the growth of embryos (stage 11 to 22).
Semi-quantitative RT-PCR
To determine xMD3 expression, total RNA from 40 optic vesicles [stage 25;
without staining as described in McDonough et al. (2012)] and 50 eyes
(stage 42; removal of epidermis in rostro-caudal manner and eye isolation)
was extracted following the manufacturer instructions (RNeasy mini kit,
Qiagen) and a semi-quantitative PCRwas performed for MD3 and GAPDH,
with the following primers respectively: MD3 Fw, ACAATGAGAGATT-
CTGTTACAGACGGGG; MD3 Rv, AAGCTCCCAACAGTTACAGCA-
TCCATGGCT; GAPDH Fw, ACTGCCACCCAGAAGAC; GAPDH Rv,
AAGTGCTTATTCCTTAGATG.
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DNA constructs
MD3 antisense probe was generated by amplifying the MD3 ORF 3′-end
using the following primers, Fw: CCCGGGGGATCCATGAGAGATTCT-
GTTACAGACG, Rv: CGGTGGCGGCCGTCAGCAGATCAGGATCAGC
and inserted in pBluescript BamH1/Eag1 restriction sites. MD3
overexpression and rescue constructs were obtained by subcloning GFP
tagged-full-length MD3 (GFP FL MD3) in pCS2+ (BamH1/EcoR1; Fw:
GTTCGCGGATCCGCCACCATGGTGAGCAAGGGCGAG; Rv: CTTC-
CGGAATTCTCAAACATAGTTGTTGGGTTTCTTTTTTAAC) and a
mutant MD3 (7mut-MD3) in pCS2+ (BamH1/EcoR1; Fw: GTTCGCGG-
ATCCGCCACCATGAGgGAcTCaGTaACtGAtGGcGAGAATCGGGCA-
CCTAG; Rv: CTTCCGGAATTCTCAAACATAGTTGTTGGGTTTCTT-
TTTTAAC; mutated bases are in lower cases).
Whole-mount in situ hybridization (WISH) and morpholinos
The embryos were fixed in MEMFA [0.1 M MOPS (3-N-morpholino)
propane-sulfonic acid], 2 mM EGTA (ethylene glycol tetra-acetic acid),
1 mM MgSO4, 3.7% formaldehyde. X-gal staining and WISH were
performed as described in Luehders et al. (2015). Control (CT), Morpholino
(MO) and MarvelD3 (MD3) MOs were purchased from Gene Tools (CT
MO: CCTCTTACCTCAgTTACAATTTATA; MD3A MO: AGACCCAA-
ATCTTCCTTTTGTTCCC; MD3B MO: CCCGTCTGTAACAGAATCT-
CTCATT). MD3A MO was designed to target the 5′-UTR (untranslated
region) of MD3, while MD3B MO sequence overlapped the start codon of
MD3 ORF (open reading frame).
Histology, immunocytochemistry and immunoblot
For Hematoxylin and Eosin (H&E) histological staining, embryos (stage 42)
were fixed 1 h at room temperature in MEMFA and equilibrated in 30%
sucrose, before embedding in OCT compound (Tissue Plus, Scigen, USA)
for cryo-sectioning (thickness: 8 μm; Leica). For immunocytochemistry, the
embryos were rinsed once in water, fixed overnight in 4% PFA at room
temperature for β-crystallin staining or 1 h in MEMFA at room temperature,
followed by an overnight incubation at −20°C in Dent’s fixative (4 volumes
methanol:1 volume DMSO) for Rhodopsin and Hu-C/Hu-D staining. Next,
the embryos in Dent’s fixative were rehydrated, equilibrated in 30% sucrose
at room temperature, and embedded in OCT compound before
cryosectioning (thickness: 8 μm, Leica). The eye sections were post-fixed
in 4% paraformaldehyde, blocked in PBST [0.3% Triton X100 in PBS
(phosphate buffer saline)] with 10% goat serum or bovine serum albumin
(BSA), then incubated with the following primary antibodies: monoclonal
mouse anti-β-crystallin (Abcam; ab90379), mouse anti-Hu-C/Hu-D (Life
technologies; A21271) and polyclonal rabbit anti-Rhodopsin (H-100; sc-
15382, Santa Cruz) antibodies. For immunoblots, 20 ACs were
homogenized in RIPA lysis buffer (50 mM Tris-HCl pH8, 150 mM NaCl,
1%Nonidet 40, 0.5% sodium deoxycholate, 0.1% SDS, cocktail of protease
inhibitors). Protein expression was then determined with polyclonal anti-
GFP (Invitrogen) and anti-Actin (A2066, Sigma Aldrich) antibodies.
Proliferation and apoptosis assays
To assess cell proliferation, the embryos were injected with BrdU (30 nl of
10 mM 5-Bromo-2′-deoxyuridine) in the anterior neural tube, harvested 2 h
later (stage 17) in MEMFA and processed for cryo-sectioning. Sections were
stained as described in Auger et al. (2012). To determine cell death, embryos
(stage 30) were fixed in methanol and processed for a whole-mount TUNEL
(terminal deoxynucleotidyl transferase dUTP nick-end labelling) assay (http://
tropicalis.berkeley.edu/home/gene_expression/TUNEL/TUNEL.html).
Reporter assay
The promoter activity of AP1-Luc plasmid was determined by co-injection
with pRL-CMV (Promega; as a normalization control), c-Jun RNA
(positive control) and FL MD3 RNA. Embryos (stage 12) were processed
as triplicates for the reporter assay following the instructions of the
manufacturer (Dual Luciferase reporter assay; Promega).
Imaging
A SMZ 1500 Nikon microscope (Apochromat HR Plan 0.5×/W. D. 136 mm
objective; camera Digital Sight DS-Fi2; Nikon) was used for morphological
analyses, while a LSM710 confocal microscope (C-Apochromat 40×/1.2 N.
A. objective; Zeiss) was used for immunocytochemistry on eye sections. All
images were analysed with ImageJ (https://imagej.nih.gov/ij/).
Quantification and statistics
Specific cell types in the eye were quantified by determining the ratio of the
number of cells positive for a given eye marker divided by the number of
nuclei in the same eye section. The total number of cells corresponds to the
number of nuclei per eye section visualized by Hoechst staining. The eye
size corresponds to the ratio of the injected side(height/width):non-injected
side(height/width) in Fig. 3D, and ratio of the injected side(lens/retina):non-
injected side(lens/retina) in Figs 3E, 8F, 9E, and Fig. S5D. The height and
width correspond to the dorso-ventral and the antero-posterior length of the
retina, respectively. The lens and retina were measured along the antero-
posterior axis of the eye. The eye-field transcription factors expression
domain area corresponds to the ratio of the injected side:non-injected side in
Fig. S4. All measurements were performed with ImageJ. We quantified the
number of BrdU-positive cells per section of the anterior region of the
embryo for the proliferation assay (Figs 6C and 7G) and the number of
TUNEL-positive cells per embryo for the apoptotic assay (Figs 6D and 7H).
Error bars indicate s.e.m.; P values (NS, non-significant; *P<0.05;
**P<0.01; ***P<0.001) were determined based on three independent
experiments using Mann–Whitney or Student’s t-test.
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